Gemini Therapeutics (GMTX) Peer Comparison

$23.93

$2.71 (12.77%)

As on 17-Feb-2023 09:30EDT

Market cap

$58 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.7

Div. Yield

0 %

Edit

	Gemini Therapeutics (GMTX)	Idera Pharmaceuticals (IDRA)
Market cap ($ Mln)	58	27
Revenue ($ Mln)	--	0
Net Profit ($ Mln)	-43.42	-16.70
Net Margin (%)	-8,666.87	-34,087.76
RoE (%)	-40.17	-71.67
Price to Earnings	--	--
Price-To-Book	0.68	0.84

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Gemini Therapeutics (GMTX)	Idera Pharmaceuticals (IDRA)
Operating Revenue	0.00	0.05
Cost of Revenue	0.00	2.84
Gross Profit	--	--
Operating Expenses	43.89	18.73
Operating Profit (EBIT)	-43.89	-23.00
Other Income	0.50	0.00
Profit before Tax	-43.42	-22.74
Provision for Tax	0.00	-6.04
Profit after Tax (Net Income)	-43.42	-16.70
Minority Interest	0.00	0.00
Consolidated Profit	-43.42	-16.22

Liabilities ($ Mln)

	Gemini Therapeutics (GMTX)	Idera Pharmaceuticals (IDRA)
Shareholder's Funds	104.57	20.77
Minority Interest	0.00	0.00
Non-Current Liabilities	0.00	63.68
Current Liabilities	1.46	19.23
Total Liabilities	140.44	34.86

Assets ($ Mln)

	Gemini Therapeutics (GMTX)	Idera Pharmaceuticals (IDRA)
Non-Current Assets	1.37	73.61
Current Assets	104.66	30.07
Total Assets	140.44	34.86
Total Debt*	0.00	0.63
Net Current Assets	103.20	10.84

Cashflow ($ Mln)

	Gemini Therapeutics (GMTX)	Idera Pharmaceuticals (IDRA)
Cash From Operating Activities	-59.70	-24.60
Cash Flow from Investing Activities	0.34	4.50
Cash from Financing Activities	191.48	19.41
Net Cash Inflow / Outflow	--	--

Ratios

Profitability Ratios

	Gemini Therapeutics (GMTX)	Idera Pharmaceuticals (IDRA)
ROCE (%)	-58.07	-326.90
ROE (%)	-40.17	-71.67
ROA (%)	-31.50	-19.92
EBIT Margin (%)	--	-46,093.88
Net Margin (%)	-8,666.87	-34,087.76
Cash Profit Margin (%)	--	-2.13

Growth Ratios

	Gemini Therapeutics (GMTX)	Idera Pharmaceuticals (IDRA)
Revenue Growth (%)	--	--
EBIT Growth (%)	20.08	-188.52
Net Profit Growth (%)	20.85	-165.48
EPS Growth (%)	--	--
Book Value Growth (%)	--	--

Valuation Ratios

	Gemini Therapeutics (GMTX)	Idera Pharmaceuticals (IDRA)
Price / Earnings	--	--
Price / Book Value	--	--
Dividend Yield (%)	--	--
EV/EBITDA	1.89	-0.32
Market Cap ($ Cr)	--	--

Solvency Ratios

	Gemini Therapeutics (GMTX)	Idera Pharmaceuticals (IDRA)
Debt to Equity	0.00	0.00
Short term debt to equity ratio	0.00	0.01
Current Ratio	71.49	1.56
Quick Ratio	71.49	1.56
Interest Coverage	-179.92	-144.78

Operating Efficiency Ratios

	Gemini Therapeutics (GMTX)	Idera Pharmaceuticals (IDRA)
Debtors to sales (%)	--	4,008.16
Asset Turnover	0.00	0.00
Receivable days	--	--
Inventory Days	--	--
Payable days	--	--
Cash Conversion Cycle	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly